Didier Clénet Sanofi

Didier has joined R&D Formulation & Stability platform of Sanofi in 2011. He focuses his work on high throughput screening formulations, stability prediction using advanced kinetics, particulate matter in vaccines and adjuvants characterization. For more than 15 years in Sanofi R&D, Didier was dedicated on physical and biophysical characterization of active ingredients, freeze-dried products and monoclonal antibodies (mAbs, ADC). Didier implemented Biophysical lab and a lab-automation platform for bioproduct formulations. He is coatching young scientists and performed courses in several Universities.